Phosphorescent silicon dot nano-enzyme and application thereof in biochemical detection and triple anti-counterfeiting
The synthesis of phosphorescent silicon dot nanoenzymes through the heating reaction of silicon source, iodide, heme and phosphorus sources solves the complex problem of room temperature phosphorescent silicon quantum dot material preparation, and realizes efficient detection of carmine and thiopronin and triple anti-counterfeiting labels The application improves detection accuracy and anti-counterfeiting information security.
Patent Information
- Application Number
- CN202410998750.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-24
AI Technical Summary
In the prior art, the preparation method of room temperature phosphorescent silicon quantum dot material is complicated and time-consuming, making it difficult to realize matrix-free, ultra-long life phosphorescent silicon dot nanoenzymes, and there are large measurement errors and efficiency in the detection of carmine and thiopronin. Low problem.
The phosphorescent silicon dot nanoenzyme is synthesized by heating reaction using silicon source, iodide, heme and phosphorus sources, combined with fluorescence and phosphorescence dual signal reading to achieve rapid and sensitive detection of carmine red, and detect thioprol by ultraviolet light-induced oxidase activity Ning, prepare triple anti-counterfeiting labels.
The preparation of phosphorescent silicon point nanoenzymes without substrates and ultra-long life has been realized, the selectivity and accuracy of carmine detection has been improved, and the on-site rapid visual inspection of thiopronin has been realized, and a multi-information anti-counterfeiting encryption system has been constructed, which has been improved. Anti-counterfeiting information security.
Smart Images

Figure CN118931535A_ABST
Abstract
Description
Technical Field
[0001] This application belongs to the technical field of nanomaterials and bio-functional materials, and more specifically, relates to phosphorescent silicon dots nanozymes, their preparation methods and applications. Background Art
[0002] Silicon quantum dots (SiQDs), as candidates to replace existing semiconductor quantum dots, have attracted much attention from researchers. Designing and developing nanomaterials with phosphorescence, fluorescence and oxidase activity is a current emerging research hotspot.
[0003] Room temperature phosphorescence (RTP) materials have the advantages of long lifetime, visible light emission by the naked eye, large Stokes shift, good stability, high signal-to-noise ratio, etc. Compared with conventional SiQDs that rely solely on changes in fluorescence signals, multi-parameter or multi-responsive phosphorescent SiQDs can effectively improve the selectivity and accuracy of detection. The RTP performance of nanomaterials is usually obtained by embedding them in a matrix. However, selecting a suitable matrix is very time-consuming and the preparation process is complex, severely restricting the further development of RTP materials. There is an urgent need to develop a simple, rapid and environmentally friendly method for preparing matrix-free, ultra-long lifetime non-matrix-assisted room temperature phosphorescent SiQDs.
[0004] Carmine, as an artificial coloring agent, can produce aromatic amines, which may cause nucleic acid mutations. Long-term or large intake of carmine is extremely harmful to organisms. Currently, it is mainly detected by single-signal readout methods, which have problems such as large measurement errors and low efficiency. Phosphorescent nanomaterials usually exhibit emission at longer wavelengths after removing the excitation source. Compared with single fluorescence, they have a larger Stokes shift, which can avoid interference from the excitation light and self-absorption. At the same time, the long phosphorescence lifetime enables their emission to be applied to detection at an appropriate time gate, thus avoiding spectral interference from the system and light scattering. Developing a method based on dual-signal readout of fluorescence and phosphorescence, which can quickly, sensitively, efficiently and accurately detect carmine, is of great significance.
[0005] Tiopronin (N-(2-mercaptopropionyl)glycine, TPN) is a drug used to treat heavy metal poisoning, cystinuria and liver diseases. Currently, it is mainly detected by fluorescence method, colorimetry, chemiluminescence method and high performance liquid chromatography, but the above methods have strong dependence on experimental instruments and cannot achieve on-site rapid visual detection.
[0006] The anti-counterfeiting performance of anti-counterfeiting labels with a single anti-counterfeiting output mode is relatively poor, and there is an urgent need to develop anti-counterfeiting labels with multiple anti-counterfeiting modes. Compared with fluorescent anti-counterfeiting materials, phosphorescent anti-counterfeiting materials have a longer lifespan, higher stability, and scarcity. Enzymatic color change anti-counterfeiting is easy to observe with the naked eye and has the characteristic of irreversibility. Developing triple anti-counterfeiting labels with fluorescence, phosphorescence, and enzymatic color change can encode optical information on the spatial or temporal scale compared with traditional single-light information encrypted static anti-counterfeiting labels, making them difficult to copy, and providing a development prospect for high-security anti-counterfeiting applications. Summary of the Invention
[0007] Aiming at the defects of the prior art, the purpose of this application is to provide phosphorescent silicon dot nanozymes and their applications in biochemical detection and triple anti-counterfeiting, aiming to provide phosphorescent silicon dot nanozymes with phosphorescence, fluorescence, and photoinduced oxidase activity, which can detect carmine quickly, sensitively, efficiently, and accurately through dual-signal readout of fluorescence and phosphorescence, and can be used for on-site rapid visual detection of tiopronin, as well as the preparation of triple anti-counterfeiting labels.
[0008] To achieve the above purpose, this application provides a preparation method of phosphorescent silicon dot nanozymes, including the following steps:
[0009] Mix the first silicon source, iodide, heme, and phosphorus source evenly, carry out a heating reaction, and obtain a solid product after cooling; mix the above solid product and water evenly, and obtain phosphorescent silicon dot nanozymes through centrifugation, dialysis, and freeze-drying.
[0010] Preferably, the above first silicon source is at least one of N-[3-(trimethoxysilyl)propyl]ethylenediamine, dimethyloctadecyl[3-trimethoxysilylpropyl]ammonium chloride, and 3-(2-aminoethylamino)propylmethyldimethoxysilane; and / or,
[0011] The above iodide is selected from at least one of potassium iodide, sodium iodide, and sodium periodate; and / or,
[0012] The above phosphorus source is selected from at least one of phosphoric acid, sodium dihydrogen phosphate, and sodium pyrophosphate.
[0013] Preferably, the mass ratio of the above first silicon source, iodide, heme, and phosphorus source is (100-150):(4-5):(0.1-0.5):(9-12).
[0014] Preferably, the temperature of the above heating reaction is 80°C-90°C, and the time is 2 min-30 min.
[0015] This application provides a phosphorescent silicon dot nanozyme prepared according to the above preparation method.
[0016] On the other hand, the present application also provides an aqueous-phase phosphorescent silicon dot nanozyme of the above-mentioned phosphorescent silicon dot nanozyme.
[0017] Preferably, the preparation method of the above aqueous-phase phosphorescent silicon dot nanozyme comprises the following steps:
[0018] Mix the above-mentioned phosphorescent silicon dot nanozyme, the second silicon source, ammonia water and water evenly, and the reaction solution is subjected to hydrolysis, condensation and polymerization reactions in sequence to obtain the aqueous-phase phosphorescent silicon dot nanozyme.
[0019] Preferably, the above second silicon source is selected from ethyl silicate or tetraethoxysilane.
[0020] Preferably, the volume ratio of the above second silicon source, ammonia water and water is (0.5-1):(0.5-1):(9-18).
[0021] Preferably, the concentration of the phosphorescent silicon dot nanozyme in the above reaction solution is 100 μg / mL to 300 μg / mL.
[0022] On the other hand, the present application also provides a hydrogel containing the above-mentioned phosphorescent silicon dot nanozyme.
[0023] The present application also provides the application of the above-mentioned phosphorescent silicon dot nanozyme or the above aqueous-phase phosphorescent silicon dot nanozyme in detecting carmine.
[0024] The present application also provides the application of the above-mentioned phosphorescent silicon dot nanozyme or the above hydrogel in detecting tiopronin.
[0025] The present application also provides the application of the above-mentioned phosphorescent silicon dot nanozyme in preparing a triple anti-counterfeiting label with fluorescence, phosphorescence and enzymatic color change.
[0026] Generally speaking, compared with the prior art through the above technical solutions conceived by the present application, the following technical advantages are mainly possessed:
[0027] (1) For the preparation method of the phosphorescent silicon dot nanozyme provided by the present application, by optimizing and screening halides and other nanozyme synthesis raw materials, using a silicon source, iodide, heme and a phosphorus source as raw materials, the phosphorescent silicon dot nanozyme is synthesized by a one-step hydrothermal method, which has yellow-green room temperature phosphorescence, a long phosphorescence lifetime, blue fluorescence and excellent ultraviolet light-induced oxidase activity. Compared with the prior art, the materials used in the preparation method of the phosphorescent silicon dot nanozyme provided by the present application are environmentally friendly and harmless, do not require a matrix, have the advantages of simple, fast synthesis steps, no need for high temperature, and no need for complex instruments, and have great promotion value.
[0028] (2) The phosphorescent silicon dot nanozyme provided by this application has phosphorescent and fluorescent properties. The fluorescence mode detection based on the phosphorescent silicon dot nanozyme and the phosphorescence mode detection based on the aqueous-phase silicon dot nanozyme have excellent selectivity and high responsiveness to carmine, can achieve sensitive detection of carmine, and have a mutual verification function, can effectively avoid the interference of non-target factors, and have high detection accuracy in complex real samples.
[0029] (3) The phosphorescent silicon dot nanozyme provided by this application has ultraviolet light-induced oxidase activity, can achieve the detection of TPN, and has excellent selective responsiveness to TPN, and has good recovery rate, reproducibility and strong applicability in the detection of actual biological samples. In a preferred embodiment, the lower limit of detecting TPN reaches 9.8 nM. Further, the hydrogel loaded with silicon dot nanozyme provided by this application can visually detect the TPN concentration of the sample, and has weak dependence on experimental instruments, realizing the on-site rapid detection of the TPN concentration of the sample.
[0030] (4) The phosphorescent silicon dot nanozyme provided by this application can be used to prepare a triple anti-counterfeiting system. By combining fluorescence characteristics, non-matrix-assisted RTP properties and photoinduced oxidase activity, a multi-information anti-counterfeiting encryption system is successfully constructed, which has application potential in information anti-counterfeiting encryption. Compared with traditional anti-counterfeiting technologies, the fluorescence, RTP and color development multi-mode information encryption technology of the phosphorescent silicon dot nanozyme provided by this application can achieve a higher level of anti-counterfeiting information security. Description of the Drawings
[0031] Figure 1 is the characterization of SiQDs@heme prepared in this application, where content (a) is the TEM image and content (b) is the particle size distribution histogram;
[0032] Figure 2 is the infrared spectrum and XPS spectrum of SiQDs@heme prepared in this application, where content (a) is the FT-IR spectrum and content (b) is the XPS spectrum;
[0033] Figure 3 is the XPS image of SiQDs@heme prepared in this application, where content (a) is C1s, content (b) is N1s, content (c) is O1s, content (d) is P 2p, content (e) is Si 2p, and content (f) is I 3d;
[0034] Figure 4 is the ultraviolet absorption diagram and fluorescence / phosphorescence emission spectrum of SiQDs@heme prepared in this application, where content (a) is the ultraviolet absorption diagram and content (b) is the fluorescence / phosphorescence emission spectrum under the best excitation;
[0035] Figure 5are the fluorescence and phosphorescence properties of SiQDs@heme prepared in this application, where content (a) is the fluorescence / phosphorescence spectra at different excitation wavelengths, content (b) is the CIE chromaticity diagram, content (c) is the fluorescence decay diagram of the SiQDs@heme solution, and content (d) is the phosphorescence lifetime of the SiQDs@heme solid powder;
[0036] Figure 6 is the oxidase-like activity of SiQDs@heme prepared in this application, where content (a) is the UV absorption spectrum of TMB, content (b) is the stepped behavior of the photoinduced oxidation activity of SiQDs@heme under continuous on / off of the light source, content (c) is the Michaelis-Menten curve of the catalytic activity of SiQDs@heme with TMB as the substrate, and content (d) is the Lineweaver-Burk curve of the catalytic activity of SiQDs@heme with TMB as the substrate;
[0037] Figure 7 is the phosphorescence duration diagram of SiQDs synthesized with the participation of different halogen elements;
[0038] Figure 8 The photoinduced enzyme activity and phosphorescence phenomenon of SiQDs synthesized from metal salts and the heme protein family, where content (a) is the difference in photoinduced enzyme activity and content (b) is the phosphorescence phenomenon;
[0039] Figure 9 is the effect of detecting carmine by SiQDs@heme prepared in this application, where content (a) is the fluorescence emission spectrum of SiQDs at different carmine concentrations, content (b) is the fluorescence emission linear calibration diagram of carmine, content (c) is the phosphorescence emission spectrum of SiQDs at different carmine concentrations, and content (d) is the phosphorescence emission linear calibration diagram of carmine;
[0040] Figure 10 is the UV absorption spectrum after mixing SiQDs@heme and carmine prepared in this application, as well as the fluorescence / phosphorescence emission spectra of SiQDs@heme;
[0041] Figure 11 is the selective response ability of SiQDs@heme prepared in this application, where content (a) is the response ability of the fluorescence performance of SiQDs@heme to metal and dye interference substances, content (b) is the response ability of the phosphorescence performance of SiQDs@heme to metal and dye interference substances, content (c) is the response ability of the fluorescence performance of SiQDs@heme to sugar and amino acid interference substances, and content (d) is the response ability of the phosphorescence performance of SiQDs@heme to sugar and amino acid interference substances;
[0042] Figure 12The effect of SiQDs@heme prepared in this application for detecting TPN. Among them, content (a) is the absorption spectrum of TMB at different TPN concentrations for SiQDs@heme, content (b) is the linear calibration graph of absorbance for different concentrations of TPN, content (c) is the selective response ability to TPN, and content (d) is the linear calibration graph for detecting TPN by gel colorimetric sensing;
[0043] Figure 13 A multi - information anti - counterfeiting encryption system based on SiQDs@heme. Among them, content (a) shows that the areas coated with SiQDs@heme ink and conventional SiQDs ink show blue fluorescence under ultraviolet light irradiation, content (b) shows that after turning off the ultraviolet light, the area coated with SiQDs@heme ink shows yellow - green phosphorescence, and content (c) shows that after applying the color - developing agent TMB and irradiating with ultraviolet light for 1 min, the area coated with SiQDs@heme ink shows blue. Detailed implementation manners
[0044] In order to make the purpose, technical solutions and advantages of this application more clear and understandable, the following further details this application in combination with embodiments. It should be understood that the specific embodiments described here are only used to explain this application and are not used to limit this application.
[0045] This application provides a preparation method of phosphorescent silicon dot nanozyme, including the following steps:
[0046] Mix the first silicon source, iodide, heme and phosphorus source evenly, carry out a heating reaction, and obtain a solid product after cooling; mix the solid product and water evenly, and obtain phosphorescent silicon dot nanozyme, namely SiQDs@heme, through centrifugation, dialysis and freeze - drying.
[0047] In some embodiments, the above - mentioned first silicon source is at least one of N - [3 - (trimethoxysilyl) propyl] ethylenediamine, dimethyloctadecyl [3 - trimethoxysilylpropyl] ammonium chloride and 3 - (2 - aminoethylamino) propylmethyldimethoxysilane.
[0048] In some embodiments, the above - mentioned iodide is selected from at least one of potassium iodide, sodium iodide and sodium periodate. In some embodiments, the above - mentioned phosphorus source is selected from at least one of phosphoric acid, sodium dihydrogen phosphate and sodium pyrophosphate.
[0049] In some embodiments, the mass ratio of the above - mentioned first silicon source, iodide, heme and phosphorus source is (100 - 150):(4 - 5):(0.1 - 0.5):(9 - 12).
[0050] In some embodiments, the above heating temperature is 80°C to 90°C, and the heating time is 2 min to 30 min. It can be understood that the present application does not limit the above heating method, which can be but is not limited to the microwave method, the hydrothermal method. In some embodiments, the phosphorescent silicon dot nanozyme is prepared by the microwave method. The present application does not limit the instrument used in the microwave method, the microwave treatment time, etc. Those skilled in the art can select a suitable instrument for treatment according to the actual situation, for example but not limited to heating with a microwave oven (750W) for 6 min.
[0051] In the present application, the above solid product and water are mixed evenly, aiming to disperse the solid product in water, and large particle impurities are removed by subsequent centrifugation. The present application does not limit the mass ratio of the solid product to water, as long as the solid product can be evenly dispersed in water. The present application also does not limit the above mixing method, which can be but is not limited to ultrasonic treatment. In some embodiments, dialysis is carried out using a dialysis bag with a molecular weight cut-off of 500 Da to remove minute impurities, and then a light yellow powder, that is, the phosphorescent silicon dot nanozyme, is obtained by freeze-drying.
[0052] The present application also provides a phosphorescent silicon dot nanozyme prepared by the above preparation method.
[0053] The present application also provides an aqueous-phase phosphorescent silicon dot nanozyme containing the above phosphorescent silicon dot nanozyme.
[0054] In some embodiments, the preparation method of the above aqueous-phase phosphorescent silicon dot nanozyme includes the following steps:
[0055] The above phosphorescent silicon dot nanozyme, a second silicon source, ammonia water and water are mixed evenly, and the reaction solution undergoes hydrolysis, condensation and polymerization reactions in sequence to obtain an aqueous-phase phosphorescent silicon dot nanozyme, that is, SiQDs@heme-TEOS.
[0056] In the above reaction process of the present application, the second silicon source hydrolyzes to generate silicon hydroxide, and then forms covalent bonds (Si-O-C) and hydrogen bonds with the above phosphorescent silicon dot nanozyme, enabling the phosphorescent silicon dot nanozyme to be embedded in the silica network and enhancing the rigidity of the cross-linked framework, thereby effectively suppressing non-radiative dissipation and preventing the negative impact of dissolved oxygen, and realizing aqueous-phase phosphorescence.
[0057] In some embodiments, the above second silicon source is selected from ethyl silicate or tetraethoxysilane.
[0058] In some embodiments, the volume ratio of the above second silicon source, ammonia water and water is (0.5 - 1):(0.5 - 1):(9 - 18).
[0059] In some embodiments, the concentration of the phosphorescent silicon dot nanozyme in the above aqueous-phase phosphorescent silicon dot nanozyme is 100 μg / mL to 300 μg / mL. It can be understood that those skilled in the art can adjust the concentration of the phosphorescent silicon dot nanozyme in the aqueous-phase phosphorescent silicon dot nanozyme according to actual needs, which are all within the protection scope of this application.
[0060] The phosphorescent silicon dot nanozyme and the aqueous-phase phosphorescent silicon dot nanozyme prepared in this application can be used to detect carmine. The phosphorescent silicon dot nanozyme prepared in this application can exhibit blue fluorescence, and the fluorescence emission intensity is quenched in direct proportion to the carmine concentration. The specific steps for detecting carmine in a test sample based on the phosphorescent silicon dot nanozyme are as follows:
[0061] S1. Mix the above-mentioned aqueous solution of SiQDs@heme, PBS solution, and carmine standard solutions with different concentrations, where the concentration of the carmine standard solution is greater than or equal to 0, and measure the fluorescence intensity of the mixed solution at the emission wavelength of 446 nm under the excitation wavelength of 370 nm. The fluorescence intensity of the mixed solution when the concentration of the carmine standard solution is 0 is F 0 , and the fluorescence intensity of the mixed solution with different concentrations of the carmine standard solution is F, calculate the fluorescence intensity difference (Δ fluorescence intensity) = F 0 -F;
[0062] S2. Taking the carmine concentration as the independent variable and Δ fluorescence intensity F 0 -F as the dependent variable, analyze to obtain the relationship between the carmine concentration and Δ fluorescence intensity F 0 -F;
[0063] S3. Extract the carmine from the test sample, then mix it evenly with the above-mentioned aqueous solution of the carbon dot nanozyme and PBS, measure the fluorescence intensity Fn at the emission wavelength of 446 nm under the excitation wavelength of 370 nm, and calculate the fluorescence intensity difference F 0 -Fn;
[0064] S4. Substitute the fluorescence intensity difference F 0 -Fn of the test sample into the relationship formula in S2 to obtain the carmine concentration of the test sample.
[0065] In some embodiments, the lower limit for the above phosphorescent silicon dot nanozyme to detect carmine is 0.33 μM.
[0066] The phosphorescent silicon dot nanozyme prepared in this application can exhibit yellow-green phosphorescence, and the phosphorescence emission intensity is quenched in direct proportion to the carmine concentration. The specific steps for detecting carmine in a test sample based on the aqueous-phase phosphorescent silicon dot nanozyme are as follows:
[0067] S1. Mix the above SiQDs@heme-TEOS, PBS solution, and carmine standard solutions with different concentrations, where the concentration of the carmine standard solution is greater than or equal to 0. Measure the phosphorescence intensity at the emission wavelength of 530 nm under the excitation wavelength of 350 nm for the mixed solution. The phosphorescence intensity of the mixed solution when the concentration of the carmine standard solution is 0 is P. 0 For the mixed solutions with carmine standard solutions of different concentrations, the phosphorescence intensity is P. Calculate the fluorescence intensity difference (Δphosphorescence intensity) = P 0 - P;
[0068] S2. Using the carmine concentration as the independent variable and Δphosphorescence intensity P 0 - P as the dependent variable, analyze to obtain the relationship between the carmine concentration and Δphosphorescence intensity P 0 - P;
[0069] S3. Extract the carmine from the sample to be tested, then mix it evenly with the above SiQDs@heme-TEOS and PBS, and measure the phosphorescence intensity Pn at the emission wavelength of 530 nm under the excitation wavelength of 350 nm. Calculate the phosphorescence intensity difference P 0 - Pn;
[0070] S4. Substitute the phosphorescence intensity difference P 0 - Pn of the sample to be tested into the relationship in S2 to obtain the carmine concentration of the sample to be tested.
[0071] In some embodiments, the lower limit for detecting carmine by the above aqueous-phase phosphorescent silicon dot nanozyme is 51 nM.
[0072] In some embodiments, the sample to be tested or the sample can be, but is not limited to, food samples, cosmetics, drugs, or combinations thereof.
[0073] It can be understood that the method of the above analysis is not limited in this application and can be, but is not limited to, linear analysis, regression analysis.
[0074] Based on the fluorescence / phosphorescence dual-mode detection platform provided by SiQDs@heme and SiQDs@heme-TEOS, this application can achieve sensitive detection of carmine, and has a mutual verification function, which can effectively avoid or reduce interference triggered by non-target factors and has high detection accuracy in complex real samples.
[0075] This application also provides a hydrogel containing the above phosphorescent silicon dot nanozyme.
[0076] In some embodiments, the preparation method of the above hydrogel includes the following steps: After stirring and mixing polyvinyl alcohol and water evenly, add the above phosphorescent silicon dot nanozyme, acrylamide, N,N'-methylenebisacrylamide, and ammonium persulfate and mix them evenly to obtain the hydrogel.
[0077] In some embodiments, the mass ratio of the above-mentioned phosphorescent silicon dot nanozyme, polyvinyl alcohol, acrylamide, N,N'-methylenebisacrylamide and ammonium persulfate is (1-2):(0.5-1):(2-3):(0.005-0.1):(0.05-0.1).
[0078] It can be understood that those skilled in the art can select other raw materials to replace the above-mentioned polyvinyl alcohol, acrylamide, N,N'-methylenebisacrylamide and ammonium persulfate to prepare a hydrogel containing the above-mentioned phosphorescent silicon dot nanozyme, which is within the protection scope of this application.
[0079] This application does not limit the size of the above-mentioned hydrogel spheres, the thickness of the hydrogel film, etc. Those skilled in the art can select appropriate sizes and thicknesses according to the requirements of the actual application scenario.
[0080] The phosphorescent silicon dot nanozyme prepared in this application and the hydrogel loaded with the phosphorescent silicon dot nanozyme both have photoinduced oxidase activity and can be used to detect tiopronin. The specific steps for detecting tiopronin in a test sample based on the phosphorescent silicon dot nanozyme are as follows:
[0081] S1. Mix the above-mentioned aqueous solution of SiQDs@heme, the chromogenic substrate solution, the PBS solution and different concentrations of TPN standard solutions, and measure the absorbance of the mixed solution at 652 nm. The absorbance of the mixed solution before adding the TPN solution is A 0 , and the absorbance of the mixed solution after adding different concentrations of TPN standard solutions is A TPN . Calculate the absorbance difference (Δ absorbance) = A 0 - A TPN ;
[0082] S2. Take the TPN concentration as the independent variable and the Δ absorbance A 0 - A TPN as the dependent variable, and analyze to obtain the relationship between the TPN concentration and the Δ absorbance A 0 - A TPN ;
[0083] S3. Extract the TPN in the test sample, then mix it evenly with the above-mentioned aqueous solution of SiQDs@heme, the chromogenic substrate solution and the PBS, and measure the absorbance An of the mixed solution at 652 nm. Calculate the absorbance difference A 0 - An;
[0084] S4. Substitute the absorbance difference A 0 - An of the test sample into the relationship in S2 to obtain the TPN concentration of the test sample.
[0085] In some embodiments, the lower limit for the above-mentioned phosphorescent silicon dot nanozyme to detect TPN is 9.8 nM.
[0086] The specific steps for detecting tiopronin in the sample to be tested using the hydrogel based on the above-mentioned phosphorus-doped luminescent silicon dots nanozyme are as follows:
[0087] S1. Place the above hydrogel in a chromogenic substrate solution and different concentrations of TPN standard solutions, irradiate with ultraviolet light, then observe the color change of the hydrogel, use the corresponding plug-in Convert of CIE to take RGB color of the gel under different concentrations of TPN, and convert it to L* / a* / b* value after deducting the blank;
[0088] S2. Take the TPN concentration as the independent variable and the L* value as the dependent variable, and analyze to obtain the relationship formula between the TPN concentration and the L* value;
[0089] S3. Extract the TPN in the sample to be tested, repeat step S1, and obtain the L* value corresponding to the TPN concentration in the sample to be tested;
[0090] S4. Substitute the L* value of the sample to be tested into the relationship formula in S2 to obtain the TPN concentration of the sample to be tested.
[0091] This application also provides the application of the above-mentioned phosphorus-doped luminescent silicon dots nanozyme in the preparation of triple anti-counterfeiting labels with fluorescence, phosphorescence and enzyme-catalyzed color change.
[0092] The above technical solutions are described in detail below in conjunction with specific embodiments. It should be understood that these are merely exemplary and are not intended to limit this application. Materials with the same or similar types, models, qualities, properties or functions as the following reagents and instruments can all be used to implement this application. The experimental methods used in the following examples are all conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples can all be obtained from commercial channels unless otherwise specified.
[0093] The following are the embodiments:
[0094] Example 1
[0095] Preparation of Phosphorescent Silicon Dot Nanozyme: Dissolve 0.1 mL of N-[3-(trimethoxysilyl)propyl]ethylenediamine (DAMO) in 5 mL of aqueous KI solution (KI concentration is 5 mM), add 0.147 mg of heme, and then stir and dropwise add 0.1 mL of phosphoric acid solution (concentration is 1.02 mol / L). Transfer the aqueous solution of the formed transparent mixture to a 50 mL beaker, and heat it in a microwave oven (750 W) for 6 min for reaction (heating temperature is 80 - 90 °C). Wait for the reactor to cool naturally to room temperature, dissolve the obtained gel-like solid in 30 mL of deionized water and sonicate for 10 min. Centrifuge the crude aqueous solution at 10,000 r for 10 min, and filter large particles or aggregated particles with a 0.22 μm filter membrane. Dialyze the collected solution (MWCO: 500 Da) for 24 h (change water every 6 h), and freeze-dry for 48 h to obtain a pale yellow powder, namely phosphorescent silicon dot nanozyme (SiQDs@heme).
[0096] To study the phosphorescence properties of the above phosphorescent silicon dot nanozyme, an aqueous-phase phosphorescent silicon dot nanozyme was prepared. The specific method is as follows: Mix 1.5 mg of SiQDs@heme, 0.5 mL of tetraethyl orthosilicate (TEOS), 0.5 mL of NH 4 OH and 14 mL of water evenly to obtain a 15 mL phosphorescent silicon dot nanozyme solution with a concentration of 100 μg / mL. Place the above solution at room temperature and stir for 16 h to carry out hydrolysis reaction, condensation reaction and polymerization reaction in sequence, and then filter it multiple times with a 0.22 μm filter membrane to collect the transparent solution, namely aqueous-phase phosphorescent silicon dot nanozyme (SiQDs@heme-TEOS). Specifically, at the initial stage of the reaction, TEOS hydrolyzes to form silicon hydroxide, and then forms covalent bonds (Si-O-C) and hydrogen bonds with SiQDs@heme, enabling SiQDs@heme to be embedded in the silica network and enhancing the rigidity of the cross-linked framework, thereby effectively inhibiting non-radiative dissipation and preventing the negative impact of dissolved oxygen, and achieving aqueous-phase phosphorescence.
[0097] Example 2
[0098] 2.1 Morphology Structure and Chemical Structure of SiQDs@heme
[0099] Observe the morphology structure of SiQDs@heme through transmission electron microscopy (TEM). As Figure 1 shown in content (a), Figure 1 content (b), SiQDs@heme is spherical, evenly dispersed, the particle size distribution is in the range of 4.29 - 9.92 nm, the average particle size is 7.38 nm, and its lattice spacing is 0.17 nm, corresponding to the (004) lattice plane of graphite 2H. The surface potential of SiQDs@heme is +6.29 mV, and the analysis is related to the surface structure of its particles.
[0100] The surface structure, elemental composition, and chemical composition of SiQDs@heme were detected by FT-IR and XPS. As Figure 2 shown in content (a), the FT-IR spectrum showed characteristic absorptions of C-O / P-O / Si-O-Si / Si-O-C, heme, and C-I at 1075.55 cm -1 , 1469.43 cm -1 , and 527.48 cm -1 , respectively. As Figure 2 shown in content (b), the XPS spectra showed that at 284.8 eV, 531.51 eV, 400.93 eV, 102.01 eV, 132.83 eV, 726.26 eV, and 618.24 eV corresponded to C 1s, O 1s, N 1s, Si 2p, P 2p, Fe 2p, and I 3d, respectively, and the corresponding contents were 41.16%, 33.16%, 10.89%, 5.84%, 6.95%, 0.32%, and 1.69%.
[0101] Furthermore, the XPS images of SiQDs@heme were analyzed. As Figure 3 shown in content (a), C 1s showed two characteristic peaks of C-C and C-O at 284.48 eV and 285.95 eV; as Figure 3 shown in content (b), N 1s showed three characteristic peaks of C-N-C, N-N, and C-N at 398.88 eV, 400.20 eV, and 401.01 eV; as Figure 3 shown in content (c), O 1s showed C=O characteristic peaks at 530.24 eV and 531.79 eV; as Figure 3 shown in content (d), P 2p showed two characteristic peaks of P-O and P-C / P-N at 132.57 eV and 133.49 eV; as Figure 3 shown in content (e), Si 2p showed two characteristic peaks of C-Si-O and Si-O at 101.90 eV and 102.62 eV; as Figure 3 shown in content (f), I 3d showed two characteristic peaks of I 2 + and I - at 618.13 eV and 618.33 eV.
[0102] 2.2 Fluorescence and phosphorescence properties of SiQDs@heme
[0103] 1) Dissolve the above SiQDs@heme in deionized water to obtain an SiQDs@heme aqueous solution, and then place it in the detection cell of an ultraviolet-visible spectrophotometer to detect the absorbance at different wavelengths, so as to detect the fluorescence performance of SiQDs@heme. Place the above SiQDs@heme-TEOS in the detection cell of an ultraviolet-visible spectrophotometer to detect the absorbance at different wavelengths, so as to detect the phosphorescence performance of SiQDs@heme.
[0104] As Figure 4 shown in content (a), SiQDs@heme exhibits one main absorption peak at 341 nm, and SiQDs@heme-TEOS exhibits one main absorption peak at 258 - 285 nm.
[0105] 2) Place the SiQDs@heme aqueous solution and SiQDs@heme-TEOS in the detection cell of a fluorescence spectrophotometer respectively to measure the fluorescence intensity and phosphorescence intensity at the optimal emission wavelength, the changes in fluorescence intensity and phosphorescence intensity at different emission wavelengths, and draw the CIE chromaticity diagram.
[0106] As Figure 4 shown in content (b), the maximum emission wavelength of the SiQDs@heme aqueous solution at the optimal excitation wavelength of 370 nm is 446 nm (black line, fluorescence spectrum), and it exhibits bright blue fluorescence under 365 nm ultraviolet light irradiation (the left inset shows the daylight lamp picture and fluorescence picture of the SiQDs@heme aqueous solution in sequence); the maximum emission wavelength of SiQDs@heme-TEOS at the optimal excitation wavelength of 350 nm is 530 nm (red line, phosphorescence spectrum), and it exhibits yellow-green phosphorescence after 365 nm ultraviolet light irradiation (the right inset shows the daylight lamp picture, fluorescence picture and phosphorescence picture of SiQDs@heme-TEOS in sequence). As Figure 5 shown in content (a), as the excitation wavelength increases, both the fluorescence emission wavelength and the phosphorescence emission wavelength show a red shift, and the emission intensity gradually decreases. As Figure 5 shown in content (b), the fluorescence chromaticity coordinates of the SiQDs@heme aqueous solution are (0.178, 0.266), and the phosphorescence chromaticity coordinates of SiQDs@heme-TEOS are (0.172, 0.209).
[0107] 3) Detect the fluorescence lifetime, fluorescence quantum yield, phosphorescence lifetime and phosphorescence quantum yield
[0108] Test the change of the fluorescence intensity of the SiQDs@heme aqueous solution with time when the excitation / emission wavelengths are 370 nm / 446 nm respectively, and draw the fluorescence decay diagram. As Figure 5 shown in content (c), the fluorescence lifetime is 6 ns.
[0109] Using quinine sulfate (dissolved in 0.1 M H 2 SO 4 ) as a reference, the fluorescence quantum yield of SiQDs@heme (dissolved in deionized water) was calculated according to Equation (1):
[0110]
[0111] where the subscripts "sam" and "ref" refer to the sample and the reference substance, respectively; and φ ref are the QY of the sample and the QY of quinine sulfate (QY is 54.6%), respectively; A is the absorbance value; I is the integrated value of the emission intensity at the same excitation wavelength (Ex is 370 nm); n is the refractive index (n sam is 1.33, n ref is 1.36); the ultraviolet absorption intensity is kept below 0.1. After calculation, the fluorescence quantum yield of SiQDs@heme is 7.59%.
[0112] The change in the phosphorescence intensity of SiQDs@heme with time at excitation / emission wavelengths of 350 nm / 530 nm was measured, and a phosphorescence decay plot was drawn, as shown in Figure 5 Content (d). After calculation, the phosphorescence quantum yield of SiQDs@heme is 5.51%. The change data of the phosphorescence intensity were fitted using the multi-exponential decay function of Equation (2), and then the weighted average lifetime of the phosphorescence intensity was calculated according to Equation (3)
[0113] <τ> = ∑a i τ i Equation (3)
[0114] where Ai is the total amplitude, ai is the amplitude fraction, A is the amplitude, and τi is the time constant. After calculation, the phosphorescence lifetime of SiQDs@heme is 126 ms.
[0115] 2.3 UV-induced oxidase activity of SiQDs@heme
[0116] Using TMB as a chromogenic substrate, the enzyme activity of SiQDs@heme was preliminarily evaluated. 20 μL of an aqueous solution of SiQDs@heme with a concentration of 2 mg / mL, 50 μL of a TMB solution with a concentration of 3 mM, and 430 μL of a PBS solution with a concentration of 20 mM (pH 4) were added to a cuvette and mixed well, and then irradiated under a 365 nm ultraviolet lamp for 10 min (alternating on / off every 30 s). The photoinduced oxidase-like activity of SiQDs@heme was determined by detecting the absorbance at a wavelength of 652 nm.
[0117] As Figure 6 in Content (a), under the irradiation of a 365 nm ultraviolet lamp, SiQDs@heme can catalyze the oxidation of colorless TMB to produce a blue product (oxTMB), and a strong peak appears at 652 nm, indicating that SiQDs@heme has oxidase-like activity. Without ultraviolet lamp irradiation, the mixed solution of SiQDs@heme and TMB remains colorless, indicating that the oxidase-like activity of SiQDs@heme is induced by ultraviolet light. When the ultraviolet lamp is repeatedly turned on or off, as Figure 6 in Content (b), the oxidase-like activity of SiQDs@heme increases step by step, indicating that SiQDs@heme has optically controlled oxidase-like activity.
[0118] Through steady-state kinetic analysis, the photocontrolled oxidase activity of SiQDs@heme was further studied. The specific steps are as follows: Mix 20 μL of an aqueous solution of SiQDs@heme with a concentration of 2 mg / mL, 430 μL of a PBS solution with a concentration of 20 mM (pH 4), and 50 μL of a TMB solution (concentration of 0.05 - 0.5 mM). Use a UV spectrophotometer to record the absorbance at 652 nm at 30 s intervals. Obtain the Michaelis-Menten curve by plotting the initial reaction rate of SiQDs@heme and the TMB concentration, and perform double-reciprocal processing on the data of the Michaelis-Menten curve to obtain the Lineweaver-Burk plot.
[0119] As Figure 6 in Content (c), Figure 6 in Content (d) shows that the V max (maximum reaction rate) of SiQDs@heme reaches 3.4×10 -9 Ms -1 , and the K m (Michaelis constant) is 0.29 mM. Compared with some natural enzymes and artificial enzymes, the K m of SiQDs@heme is lower and the V max is larger, indicating that SiQDs@heme has a higher affinity and catalytic activity with TMB as an oxidase mimic.
[0120] Example 3
[0121] According to the method provided in Example 1, 0.15 mL of 3-(2-aminoethylamino)propylmethyldimethoxysilane was dissolved in 6 mL of NaI solution (NaI concentration was 5 mM), 0.5 mg of heme was added, and then it was stirred and 0.75 mL of sodium dihydrogen phosphate solution (concentration was 0.1 mol / L) was added dropwise. The aqueous solution of the formed transparent mixture was transferred to a 50 mL beaker and heated in a microwave oven (750 W) for 15 min for reaction (heating temperature was 80 - 90 °C). After centrifugation, dialysis, and freeze-drying, solid sample 1 was obtained.
[0122] 0.13 g of 3-(2-aminoethylamino)propylmethyldimethoxysilane was dissolved in 4.5 mL of sodium periodate solution (sodium periodate concentration was 5 mM), 0.3 mg of heme was added, and then it was stirred and 12 mg of sodium pyrophosphate was added. The aqueous solution of the formed transparent mixture was transferred to a 50 mL beaker and heated in a microwave oven (750 W) for 10 min for reaction (heating temperature was 80 - 90 °C). After centrifugation, dialysis, and freeze-drying, solid sample 2 was obtained.
[0123] According to the method of Example 1, the above samples were detected. It was found in the experiment that the aqueous solutions of the above solid samples all showed blue fluorescence under the irradiation of 365 nm ultraviolet light, and after irradiating with ultraviolet light for a period of time and then turning off the ultraviolet lamp, they could emit yellow-green phosphorescence. Further, when there was no ultraviolet lamp irradiation, the above samples could not catalyze the oxidation of colorless TMB to generate blue products, and when irradiated with 365 nm ultraviolet light, they could all catalyze the oxidation of colorless TMB to generate blue products, indicating that the oxidase activities of the above solid samples were all induced by ultraviolet light. In addition, the oxidase-like activities of the above samples were equivalent to those of the phosphorescent silicon dot nanozymes prepared in Example 1.
[0124] According to the method provided in Example 1, 1.0 mg of solid sample 1, 0.5 mL of tetraethyl orthosilicate, 0.5 mL of NH 4 OH and 9 mL of water were mixed evenly to prepare 10 mL of a solid sample 1 solution with a concentration of 100 μg / mL. The above solution was stirred at room temperature for 16 h to successively carry out hydrolysis reaction, condensation reaction, and polymerization reaction, and then it was filtered multiple times using a 0.22 μm filter membrane to collect transparent solution 1.
[0125] 6.0 mg of solid sample 2, 1 mL of tetraethoxysilane, 1 mL of NH 4 OH and 18 mL of water were mixed evenly to prepare 20 mL of a solid sample 2 solution with a concentration of 300 μg / mL. The above solution was stirred at room temperature for 16 h to successively carry out hydrolysis reaction, condensation reaction, and polymerization reaction, and then it was filtered multiple times using a 0.22 μm filter membrane to collect transparent solution 2.
[0126] After testing, both transparent solution 1 and transparent solution 2 can exhibit yellow-green phosphorescence, achieving aqueous-phase phosphorescence.
[0127] Comparative Example 1
[0128] NaF, NaCl, and KBr were respectively used to replace KI to prepare phosphorescent silicon dot nanozymes, and the remaining operations were the same as those in Example 1. The prepared phosphorescent silicon dot nanozymes doped with different halogen atoms were arranged in sequence on a black cardboard. In a dark environment, a portable ultraviolet lamp provided an excitation light source at a wavelength of 365 nm. After irradiation for 2 min, a mobile phone was used to shoot a video to record the phosphorescence emission duration of the prepared phosphorescent silicon dot nanozymes. Subsequently, the taken video was imported into Adope Premiere Pro to intercept phosphorescent emission pictures at different time nodes.
[0129] It can be seen from Figure 7 that different halides have an obvious influence on the room-temperature phosphorescence performance of phosphorescent silicon dot nanozymes. Among them, the phosphorescence duration of SiQDs@heme prepared with KI as the halogen raw material is significantly better than that of NaF, NaCl, and KBr, and the phosphorescence emission duration is effectively extended.
[0130] Comparative Example 2
[0131] MnCl 2 , FeCl 2 , CoCl 2 , GdCl 3 , and HB, these nanozyme synthesis raw materials were used to replace heme to prepare phosphorescent silicon dot nanozymes, and the remaining operations were the same as those in Example 1. The effects of changing the types of doping elements on the photoinduced oxidase activity and phosphorescence (RTP) of phosphorescent silicon dot nanozymes were analyzed and studied.
[0132] As Figure 8 shown in content (a), compared with SiQDs, the photoinduced oxidase activity of phosphorescent silicon dot nanozymes synthesized with HB, MnCl 2 , FeCl 2 , and GdCl 2 as raw materials decreased. The prepared phosphorescent silicon dot nanozymes were irradiated with a 365-nm wavelength ultraviolet lamp for 2 min, and the changes before and after the ultraviolet lamp irradiation were observed. As Figure 8 shown in content (b), compared with SiQDs, the phosphorescent silicon dot nanozymes synthesized with CoCl 2 , MnCl 2 , FeCl 2 , and GdCl 3 as raw materials do not have RTP performance. In summary, SiQDs@heme synthesized with heme as the raw material has the highest photoinduced oxidase activity and excellent RPT performance.
[0133] Example 4 Fluorescence / Phosphorescence Dual-Mode Detection System for Detecting Carmine Based on SiQDs@heme
[0134] 4.1 Relationship between Fluorescence Intensity of SiQDs@heme and Carmine Concentration
[0135] SiQDs@heme can exhibit blue fluorescence, with an excitation wavelength / emission wavelength (λ Ex / λ Em ) of 370 nm / 446 nm. Mix 40 μL of an aqueous solution of SiQDs@heme with a concentration of 2 mg / mL, 860 μL of PBS (pH 4) solution, and 100 μL of carmine standard solutions with different concentrations. Measure the fluorescence emission spectrum at an excitation wavelength of 370 nm, record the fluorescence intensity at an emission wavelength of 446 nm, and construct a linear relationship between the fluorescence intensity and the carmine concentration.
[0136] As shown in Figure 9 Content (a), when SiQDs@heme reacts with carmine, the fluorescence emission intensity of SiQDs@heme quenches in a manner proportional to the carmine concentration. Figure 9 Content (b) is a curve showing the change in the difference in fluorescence intensity at an emission wavelength of 446 nm under excitation at 370 nm before and after adding carmine with respect to the carmine concentration. The fluorescence intensity of the mixture when the concentration of the carmine standard solution is 0 is F 0 , and the fluorescence intensity of the mixtures with carmine standard solutions of different concentrations is F. It can be seen that when the carmine concentration is 0 μM to 55.6 μM, the difference in fluorescence intensity at an emission wavelength of 446 nm (ΔFluorescence intensity = F 0 - F) has a linear relationship with the carmine concentration. The regression equation is y = 197.85x + 1512, and the correlation coefficient (R 2 ) is 0.9919, where x is the carmine concentration and y is the difference in fluorescence intensity at an emission wavelength of 446 nm before and after adding carmine (ΔFluorescence intensity), and the limit of detection (LOD) is 0.33 μM.
[0137] 4.2 Relationship between Phosphorescence Intensity of SiQDs@heme-TEOS and Carmine Concentration
[0138] SiQDs@heme-TEOS can exhibit yellow-green phosphorescence, with an excitation wavelength / emission wavelength (λ Ex / λ Em) With 350 nm / 530 nm, 40 μL of SiQDs@heme-TEOS with a concentration of 2 mg / mL, 860 μL of PBS (pH 4) solution, and 100 μL of carmine standard solutions with different concentrations were mixed. The phosphorescence emission spectrum was measured at a wavelength of 350 nm, and the phosphorescence intensity at the emission wavelength of 530 nm was recorded to construct the linear relationship between the phosphorescence intensity and the carmine concentration.
[0139] As Figure 9 shown in content (c), when SiQDs@heme-TEOS was mixed with carmine standard solutions with different concentrations (concentration range of 0 μM - 34.8 μM), as the concentration of the carmine standard solution increased, the phosphorescence emission intensity of SiQDs@heme decreased proportionally. Figure 9 Content (d) is the curve of the change in the difference in phosphorescence intensity at the emission wavelength of 530 nm under 350 nm excitation before and after adding carmine with respect to the carmine concentration. It can be seen that there is a linear relationship between the difference in phosphorescence intensity (Δphosphorescence intensity) at the emission wavelength of 530 nm and the carmine concentration. The regression equation is y = 123.79x + 830.01, and the correlation coefficient (R 2 ) is 0.9939, where x is the carmine concentration and y is the difference in phosphorescence intensity (Δphosphorescence intensity) at the emission wavelength of 530 nm before and after adding carmine. The limit of detection (LOD) is 51 nM.
[0140] The mechanism by which carmine quenches SiQDs@heme may be the inner filter effect (IFE). The ultraviolet-visible absorption spectrum of carmine has a broad absorption peak in the range of 370 - 580 nm (red line). When the absorption peak of the absorber (quencher carmine) in the fluorescence / phosphorescence detection system overlaps with the fluorescence emission peak (446 nm, PL) and phosphorescence emission peak (530 nm, phos.) of SiQDs@heme, the IFE strategy converts the absorption signal into a significantly quenched fluorescence / phosphorescence signal ( Figure 10 ).
[0141] 4.3 Selectivity of the fluorescence / phosphorescence detection system
[0142] By studying interfering substances including sugars (lactose, glucose), amino acids (L-lysine, L-glutamine, L-serine, glycine, D-malic acid, glutathione, cysteine), metal ions (Fe 2+ , Al 3+ , Ag + , Pb 2+ , Cu 2+ , Zn 2+ , Mn 2+ , Mg 2+ , Fe 3+The fluorescence / phosphorescence signals in the presence of dyes (methyl red, safranin, congo red, neutral red) were used to evaluate the selectivity of the fluorescence / phosphorescence detection system for carmine.
[0143] Take 40 μL of an aqueous solution of SiQDs@heme with a concentration of 2 mg / mL, 860 μL of PBS (pH 4) solution, and 40 μL of aqueous solutions of different interfering substances with a concentration of 30 μM each. Mix them well, and record the fluorescence intensity at the emission wavelength of 446 nm under the excitation wavelength of 370 nm for the mixed solution before and after adding the interfering substances. Here, F 0 represents the initial fluorescence intensity without adding any interfering substances, and F is the fluorescence intensity measured after adding different interfering substances.
[0144] Take 40 μL of SiQDs@heme-TEOS with a concentration of 2 mg / mL, 860 μL of PBS (pH 4) solution, and 40 μL of aqueous solutions of different interfering substances with a concentration of 30 μM each. Mix them well, and record the phosphorescence intensity at the emission wavelength of 530 nm under the excitation wavelength of 350 nm for the mixed solution before and after adding the interfering substances. Here, P 0 represents the initial phosphorescence intensity without adding any interfering substances, and P is the phosphorescence intensity measured after adding different interfering substances.
[0145] As Figure 11 shown in content (a), Figure 11 content (b), Figure 11 content (c), Figure 11 content (d), compared with the above interfering substances, the absorbance difference value of the fluorescence / phosphorescence detection system for carmine is the largest, showing high responsiveness to carmine and being able to be effectively applied to the detection of carmine.
[0146] In summary, the fluorescence / phosphorescence dual-mode detection platform based on SiQDs@heme can achieve sensitive detection of carmine, and has a mutual verification function, which can effectively avoid or reduce the interference triggered by non-target factors and has high detection accuracy in complex real samples.
[0147] Example 5
[0148] 5.1 TPN colorimetric sensor based on the photoinduced oxidase activity of SiQDs@heme
[0149] Mix 40 μL of an aqueous solution of SiQDs@heme with a concentration of 2 mg / mL, 100 μL of a chromogenic substrate TMB solution with a concentration of 3 mM, 760 μL of PBS (pH 4) solution, and 100 μL of TPN solutions with different concentrations, and measure the ultraviolet absorption at wavelengths from 400 to 800 nm. The characteristic absorption of TMB is at a wavelength of 652 nm.
[0150] ByFigure 12 As shown in content (a), as the concentration of TPN increases, the absorbance of the mixed solution at 652 nm gradually weakens. From Figure 12 As shown in content (b), as the concentration of TPN increases, the color of the mixed solution gradually fades (the inset shows the corresponding solution color), indicating that the interaction between TPN and SiQDs@heme inhibits the ultraviolet light-induced oxidase-like activity of SiQDs@heme. The possible reason for the analysis is that as a thiol compound, TPN can have a strong binding force with the metal ions doped on the surface of SiQDs@heme, inhibiting the catalytic active sites of SiQDs@heme, thereby reducing the production of the blue product oxTMB, resulting in a reduced or unchanged color change of TMB. The reducing property of TPN may also restore oxTMB to colorless.
[0151] Figure 12 Content (b) is the curve of the absorbance difference before and after adding TPN versus the TPN concentration. The absorbance of the mixed solution before adding the TPN solution is A 0 , and the absorbance of the mixed solution after adding different concentrations of TPN standard solutions is A TPN . It can be seen that when the TPN concentration is 0.015 μM - 25 μM, there is a linear relationship between the absorbance difference (Δ absorbance = A 0 - A TPN ) and the TPN concentration. The equation is y = 0.0216x + 0.0714, and the correlation coefficient (R 2 ) is 0.9913, where x is the TPN concentration and y is the absorbance difference at 652 nm wavelength before and after adding TPN (Δ absorbance = A 0 - A TPN ). The detection limit (LOD) of TPN is 9.8 nM.
[0152] 5.2 Selectivity of the TPN colorimetric sensor
[0153] According to the method in 5.1, 100 μL of interfering substances with a concentration of 10 μM, SiQDs@heme aqueous solution, TMB solution, and PBS solution were mixed, and the ratio of the absorbance difference (ΔA / A 0 = (A 0 - A 干扰物质 ) / A 0 ) of the mixed solution at 652 nm wavelength before and after adding interfering substances was detected to evaluate the selectivity of the TPN colorimetric sensor for TPN. The interfering substances include sugars (lactose, glucose, sucrose), amino acids (L-lysine, L-glutamine, L-serine, glycine, D-malic acid), and metal ions (Fe 2+ , Al 3+ , Cr 3+ , Pb2+ , Hg 2+ , Mg 2+ , Fe 3+ ).
[0154] From Figure 12 As can be seen from content (c), different metal ions and most biochemical substances have no effect on the colorimetric detection of TPN, and the TPN colorimetric sensor has excellent selective responsiveness to TPN.
[0155] 5.3 Performance of the TPN Colorimetric Sensor in Detecting the Concentration of Actual Drug TPN
[0156] Mix 40 μL of SiQDs@heme aqueous solution with a concentration of 2 mg / mL, 100 μL of TMB solution with a concentration of 3 mM, 760 μL of PBS (pH 4) solution and TPN enteric-coated tablets (0.1 g / tablet). The final concentration of TPN in the mixed solution is 0.05, 10 and 25 μM respectively. Detect the absorbance difference (A0 - A TPN肠溶片 ) of the mixed solution at 652 nm and substitute it into the equation in 5.1 above to obtain the detected concentration of TPN. Recovery rate = (detected concentration of TPN / added concentration of TPN) × 100%. The results of detecting the concentration of actual drug TPN by the TPN colorimetric sensor based on the photoinduced oxidase activity of SiQDs@heme are shown in Table 1.
[0157] Table 1 Spike Recovery of TPN in TPN Enteric-Coated Tablets
[0158] TPN addition concentration (μM) TPN detection concentration (μM) Recovery rate (%) RSD (%) 0.05 0.053 105.82 0.8 10 10.92 109.21 2.0 25 24.96 99.85 1.1
[0159] In Table 1, the recovery rate of TPN enteric-coated tablets is 99.85% - 109.21%, and the relative standard deviation (RSD) is less than or equal to 2.0%, indicating that the TPN colorimetric sensor has good recovery rate and reproducibility and strong applicability in the detection of biological samples.
[0160] 5.4 TPN Intelligent Gel Colorimetric Sensor Based on the Photoinduced Oxidase Activity of SiQDs@heme
[0161] Take 0.5 g of polyvinyl alcohol (PVA) and add it to 10 mL of water. Stir and dissolve it充分 in a water bath at 80 °C. Add 2.5 g of acrylamide (AM), 5 mg of N,N'-methylenebisacrylamide (MBA) and 75 mg of ammonium persulfate (APS). Ultrasonically treat for 1 min to remove the bubbles generated by stirring, and then add 400 μL of SiQDs@heme aqueous solution with a concentration of 2 mg / mL to obtain a gel solution. Use a 96-well plate as a mold, add 80 μL of the gel solution to each well, and irradiate it with a 365 nm ultraviolet lamp (4 V, 52 W) at room temperature for 1 h to obtain a PVMA hydrogel, that is, the TPN intelligent gel colorimetric sensor.
[0162] During the detection process, the above-mentioned gel was placed in TPN solutions with different concentrations and a fixed-concentration TMB solution (concentration: 3 mM) for 3 min, irradiated with ultraviolet light for 1 min, the color change of the gel was observed, and the gel under different concentrations of TPN was color-sampled in RGB using the corresponding plug-in Convert of CIE, and converted to L* / a* / b* values after blank deduction.
[0163] As Figure 12 shown in content (d), as the concentration of TPN increased, the color development of the gel gradually faded (lower inset). Analysis found that only the L* value (y) showed a good linear relationship with the TPN concentration (x), and the linear equation was y = -0.098x + 3.1022, and the correlation coefficient (R 2 ) was 0.9969.
[0164] Example 6 Multiplex information anti-counterfeiting encryption system based on SiQDs@heme
[0165] The same mass of SiQDs@heme and conventional SiQDs (only blue fluorescence, no yellow-green phosphorescence) were dissolved in water to prepare Ink 1 and Ink 2. Ink 1 was applied to cover the area of the number "666", and the rest was applied with Ink 2. As Figure 13 shown in content (a), under the irradiation of a 365 nm ultraviolet lamp, both the areas coated with Ink 1 and Ink 2 emitted blue fluorescence, presenting the字样 "888". After turning off the ultraviolet lamp, the area coated with Ink 1 emitted yellow-green phosphorescence, showing the password "666" ( Figure 13 shown in content (b)). Then, TMB (pH = 3) was made into a developer to cover the areas coated with Ink 1 and Ink 2, and after irradiating with an ultraviolet lamp for 1 min and then turning it off, due to the photoinduced oxidase activity of SiQDs@heme, the blue password "666" was visible to the naked eye in the area coated with Ink 1 ( Figure 13 shown in content (c)).
[0166] It can be seen that the SiQDs@heme prepared in this application can be used as a high-quality anti-counterfeiting ink for advanced encryption. By combining fluorescence characteristics, non-matrix-assisted RTP properties, and photoinduced oxidase activity, a multiplex information anti-counterfeiting encryption system was successfully constructed, which has application potential in information anti-counterfeiting encryption. Compared with traditional anti-counterfeiting technologies, the fluorescence, RTP, and color development multi-mode information encryption technology of SiQDs@heme provided in this application can achieve a higher level of anti-counterfeiting information security.
[0167] It is easy for those skilled in the art to understand that the above are only the preferred embodiments of this application, and are not intended to limit this application. Any modifications, equivalent replacements, and improvements made within the spirit and principles of this application shall be included in the protection scope of this application.
Claims
1. A method for preparing phosphorescent silicon dot nanozyme, It is characterized in that The steps include: The first silicon source, iodide, heme and phosphorus source are mixed evenly, heated for reaction, and cooled to obtain a solid product; the solid product and water are mixed evenly, and the mixture is centrifuged, dialyzed and freeze-dried to obtain phosphorescent silicon dot nanozyme.
2. The preparation method according to claim 1, It is characterized in that The first silicon source is at least one of N-[3-(trimethoxysilyl)propyl]ethylenediamine, dimethyloctadecyl[3-trimethoxysilylpropyl]ammonium chloride and 3-(2-aminoethylamino)propylmethyldimethoxysilane; and / or, The iodide is selected from at least one of potassium iodide, sodium iodide and sodium periodate; and / or, The phosphorus source is selected from at least one of phosphoric acid, sodium dihydrogen phosphate and sodium pyrophosphate; and / or, The mass ratio of the first silicon source, iodide, heme and phosphorus source is (100-150): (4-5): (0.1-0.5): (9-12); and / or, The heating reaction temperature is 80°C to 90°C, and the time is 2min to 30min.
3. A phosphorescent silicon dot nanozyme prepared according to the preparation method according to claim 1 or 2. 4 . An aqueous phase phosphorescent silicon dot nanozyme comprising the phosphorescent silicon dot nanozyme according to claim 3 .
5. The aqueous phosphorescent silicon dot nanozyme according to claim 4, It is characterized in that The preparation method of the aqueous phase phosphorescent silicon dot nanozyme comprises the following steps: The phosphorescent silicon dot nanozyme, the second silicon source, ammonia water and water are mixed evenly, and the reaction solution is subjected to hydrolysis, condensation and polymerization reactions in sequence to obtain an aqueous phase phosphorescent silicon dot nanozyme.
6. The aqueous phosphorescent silicon dot nanozyme according to claim 5, It is characterized in that The second silicon source is selected from ethyl silicate or tetraethoxysilane; and / or, The volume ratio of the second silicon source, ammonia water and water is (0.5-1): (0.5-1): (9-18); and / or, The concentration of the phosphorescent silicon dot nanozyme in the reaction solution is 100 μg / mL to 300 μg / mL.
7. A hydrogel comprising the phosphorescent silicon dot nanozyme according to claim 3.
8. Use of the phosphorescent silicon dot nanozyme according to claim 3 or the aqueous phase phosphorescent silicon dot nanozyme according to claim 4 in detecting carmine.
9. Use of the phosphorescent silicon dot nanozyme according to claim 3 or the hydrogel according to claim 7 in detecting tiopronin.
10. Use of the phosphorescent silicon dot nanozyme according to claim 3 in preparing a triple anti-counterfeiting label of fluorescence, phosphorescence and enzymatic color change.
Citation Information
Patent Citations
Long-service life room-temperature phosphor material and preparation method thereof
CN110157412A
Preparation of silicon nanoparticles with red fluorescence and application of silicon nanoparticles in detection of acid phosphatase
CN113956871A
